D.E. Shaw & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-279,400
| Closed | -$19M | – | 4212 |
|
|
2022
Q3 | $19M | Sell |
279,400
-14,845
| -5% | -$1.01M | 0.02% | 576 |
|
|
2022
Q2 | $9.4M | Buy |
294,245
+280,843
| +2,096% | +$8.97M | 0.01% | 1023 |
|
|
2022
Q1 | $464K | Sell |
13,402
-13,421
| -50% | -$465K | ﹤0.01% | 3250 |
|
|
2021
Q4 | $785K | Sell |
26,823
-17,833
| -40% | -$522K | ﹤0.01% | 2876 |
|
|
2021
Q3 | $1.14M | Buy |
+44,656
| New | +$1.14M | ﹤0.01% | 2413 |
|
|
2021
Q1 | – | Sell |
-18,355
| Closed | -$795K | – | 3284 |
|
|
2020
Q4 | $795K | Sell |
18,355
-74,667
| -80% | -$3.23M | ﹤0.01% | 2128 |
|
|
2020
Q3 | $5.13M | Sell |
93,022
-89,178
| -49% | -$4.92M | 0.01% | 1174 |
|
|
2020
Q2 | $11.5M | Sell |
182,200
-159,535
| -47% | -$10.1M | 0.01% | 814 |
|
|
2020
Q1 | $17.5M | Buy |
341,735
+238,735
| +232% | +$12.2M | 0.03% | 539 |
|
|
2019
Q4 | $8.19M | Sell |
103,000
-215,947
| -68% | -$17.2M | 0.01% | 934 |
|
|
2019
Q3 | $15.5M | Buy |
318,947
+228,206
| +251% | +$11.1M | 0.02% | 660 |
|
|
2019
Q2 | $4.77M | Buy |
90,741
+47,918
| +112% | +$2.52M | 0.01% | 1191 |
|
|
2019
Q1 | $2.27M | Buy |
42,823
+17,662
| +70% | +$935K | ﹤0.01% | 1511 |
|
|
2018
Q4 | $1.03M | Buy |
25,161
+5,011
| +25% | +$206K | ﹤0.01% | 1830 |
|
|
2018
Q3 | $766K | Buy |
+20,150
| New | +$766K | ﹤0.01% | 1915 |
|
|
2018
Q2 | – | Sell |
-5,494
| Closed | -$265K | – | 2760 |
|
|
2018
Q1 | $265K | Sell |
5,494
-12,803
| -70% | -$618K | ﹤0.01% | 2285 |
|
|
2017
Q4 | $720K | Buy |
+18,297
| New | +$720K | ﹤0.01% | 1947 |
|
|
2016
Q4 | – | Sell |
-82,374
| Closed | -$1.9M | – | 2701 |
|
|
2016
Q3 | $1.9M | Buy |
82,374
+66,874
| +431% | +$1.54M | ﹤0.01% | 1413 |
|
|
2016
Q2 | $257K | Sell |
15,500
-642
| -4% | -$10.6K | ﹤0.01% | 2304 |
|
|
2016
Q1 | $256K | Buy |
+16,142
| New | +$256K | ﹤0.01% | 2298 |
|